Furthermore, PRMT6 inhibitors are anticipated to become new tumor therapeutic targets because of their synergistic effects on tumor cells and components of the tumor microenvironment, which may make them particularly successful in cancer therapy. Here, PRMT6 is linked to neoplasm.